Table of Contents 1 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Overview 1.1 Product Overview and Scope of Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment 1.2 Classification of Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment by Types 1.2.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Comparison by Types (2019-2024) 1.2.2 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Share by Types in 2018 1.2.3 Delafloxacin 1.2.4 Vancomycin 1.2.5 Ceftaroline Fosamil 1.2.6 Others 1.3 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market by Application 1.3.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size and Market Share Comparison by Applications (2014-2024) 1.3.2 Cellulitis 1.3.3 Abscess 1.3.4 Surgical Wounds 1.3.5 Traumatic Wound 1.4 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market by Regions 1.4.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size (Million USD) Comparison by Regions (2014-2024) 1.4.1 North America (USA, Canada and Mexico) Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Status and Prospect (2014-2024) 1.4.2 Europe (Germany, France, UK, Russia and Italy) Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Status and Prospect (2014-2024) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Status and Prospect (2014-2024) 1.4.4 South America (Brazil, Argentina, Colombia) Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Status and Prospect (2014-2024) 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Status and Prospect (2014-2024) 1.5 Global Market Size of Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment (2014-2024) 2 Company Profiles 2.1 Paratek Pharmaceuticals, Inc. 2.1.1 Business Overview 2.1.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 Paratek Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.2 Cempra, Inc. 2.2.1 Business Overview 2.2.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 Cempra, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.3 Debiopharm International S.A. 2.3.1 Business Overview 2.3.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 Debiopharm International S.A. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.4 GlaxoSmithKline plc 2.4.1 Business Overview 2.4.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 GlaxoSmithKline plc Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.5 Furiex Pharmaceuticals, Inc. 2.5.1 Business Overview 2.5.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 Furiex Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.6 Melinta Therapeutics, Inc. 2.6.1 Business Overview 2.6.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications 2.6.2.1 Product A 2.6.2.2 Product B 2.6.3 Melinta Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.7 Actelion Pharmaceuticals Ltd. 2.7.1 Business Overview 2.7.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications 2.7.2.1 Product A 2.7.2.2 Product B 2.7.3 Actelion Pharmaceuticals Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.8 Durata Therapeutics, Inc. 2.8.1 Business Overview 2.8.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications 2.8.2.1 Product A 2.8.2.2 Product B 2.8.3 Durata Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.9 MerLion Pharmaceuticals Pte Ltd. 2.9.1 Business Overview 2.9.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications 2.9.2.1 Product A 2.9.2.2 Product B 2.9.3 MerLion Pharmaceuticals Pte Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.10 Abbott Laboratories, Inc. 2.10.1 Business Overview 2.10.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications 2.10.2.1 Product A 2.10.2.2 Product B 2.10.3 Abbott Laboratories, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.11 Macrolide Pharmaceuticals, Inc. 2.11.1 Business Overview 2.11.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications 2.11.2.1 Product A 2.11.2.2 Product B 2.11.3 Macrolide Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.12 Sanofi 2.12.1 Business Overview 2.12.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications 2.12.2.1 Product A 2.12.2.2 Product B 2.12.3 Sanofi Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.13 Albany Molecular Research, Inc. 2.13.1 Business Overview 2.13.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications 2.13.2.1 Product A 2.13.2.2 Product B 2.13.3 Albany Molecular Research, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.14 Zavante Therapeutics, Inc. 2.14.1 Business Overview 2.14.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications 2.14.2.1 Product A 2.14.2.2 Product B 2.14.3 Zavante Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.15 Merck & Co, Inc. 2.15.1 Business Overview 2.15.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications 2.15.2.1 Product A 2.15.2.2 Product B 2.15.3 Merck & Co, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.16 Bayer AG 2.16.1 Business Overview 2.16.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications 2.16.2.1 Product A 2.16.2.2 Product B 2.16.3 Bayer AG Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.17 Allergan plc. 2.17.1 Business Overview 2.17.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications 2.17.2.1 Product A 2.17.2.2 Product B 2.17.3 Allergan plc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.18 Teva Pharmaceuticals Industries Ltd. 2.18.1 Business Overview 2.18.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications 2.18.2.1 Product A 2.18.2.2 Product B 2.18.3 Teva Pharmaceuticals Industries Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.19 Pfizer, Inc. 2.19.1 Business Overview 2.19.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications 2.19.2.1 Product A 2.19.2.2 Product B 2.19.3 Pfizer, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.20 AstraZeneca 2.20.1 Business Overview 2.20.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications 2.20.2.1 Product A 2.20.2.2 Product B 2.20.3 AstraZeneca Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018) 3 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Competition, by Players 3.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Share by Players (2014-2019) 3.2 Market Concentration Rate 3.2.1 Top 5 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Players Market Share 3.2.2 Top 10 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Players Market Share 3.3 Market Competition Trend 4 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Regions 4.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Market Share by Regions 4.2 North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019) 4.3 Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019) 4.4 Asia-Pacific Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019) 4.5 South America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019) 4.6 Middle East and Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019) 5 North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue by Countries 5.1 North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue by Countries (2014-2019) 5.2 USA Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019) 5.3 Canada Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019) 5.4 Mexico Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019) 6 Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue by Countries 6.1 Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue by Countries (2014-2019) 6.2 Germany Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019) 6.3 UK Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019) 6.4 France Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019) 6.5 Russia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019) 6.6 Italy Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019) 7 Asia-Pacific Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue by Countries 7.1 Asia-Pacific Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue by Countries (2014-2019) 7.2 China Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019) 7.3 Japan Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019) 7.4 Korea Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019) 7.5 India Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019) 7.6 Southeast Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019) 8 South America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue by Countries 8.1 South America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue by Countries (2014-2019) 8.2 Brazil Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019) 8.3 Argentina Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019) 8.4 Colombia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019) 9 Middle East and Africa Revenue Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment by Countries 9.1 Middle East and Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue by Countries (2014-2019) 9.2 Saudi Arabia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019) 9.3 UAE Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019) 9.4 Egypt Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019) 9.5 Nigeria Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019) 9.6 South Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019) 10 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Segment by Type 10.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Market Share by Type (2014-2019) 10.2 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Forecast by Type (2019-2024) 10.3 Delafloxacin Revenue Growth Rate (2014-2024) 10.4 Vancomycin Revenue Growth Rate (2014-2024) 10.5 Ceftaroline Fosamil Revenue Growth Rate (2014-2024) 10.6 Others Revenue Growth Rate (2014-2024) 11 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Segment by Application 11.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Share by Application (2014-2019) 11.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Forecast by Application (2019-2024) 11.3 Cellulitis Revenue Growth (2014-2019) 11.4 Abscess Revenue Growth (2014-2019) 11.5 Surgical Wounds Revenue Growth (2014-2019) 11.6 Traumatic Wound Revenue Growth (2014-2019) 12 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Forecast (2019-2024) 12.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Forecast (2019-2024) 12.2 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Forecast by Regions (2019-2024) 12.3 North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Forecast (2019-2024) 12.4 Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Forecast (2019-2024) 12.5 Asia-Pacific Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Forecast (2019-2024) 12.6 South America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Forecast (2019-2024) 12.7 Middle East and Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Forecast (2019-2024) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology 14.2 Data Source

List of Tables and Figures Figure Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Picture Table Product Specifications of Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Table Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment and Revenue (Million USD) Market Split by Product Type Figure Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Share by Types in 2018 Figure Delafloxacin Picture Figure Vancomycin Picture Figure Ceftaroline Fosamil Picture Figure Others Picture Table Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue (Million USD) by Application (2014-2024) Figure Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Share by Applications in 2018 Figure Cellulitis Picture Figure Abscess Picture Figure Surgical Wounds Picture Figure Traumatic Wound Picture Table Global Market Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue (Million USD) Comparison by Regions 2014-2024 Figure North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue (Million USD) and Growth Rate (2014-2024) Figure Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue (Million USD) and Growth Rate (2014-2024) Figure Asia-Pacific Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue (Million USD) and Growth Rate (2014-2024) Figure South America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue (Million USD) and Growth Rate (2014-2024) Figure Middle East and Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue (Million USD) and Growth Rate (2014-2024) Figure Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue (Million USD) and Growth Rate (2014-2024) Table Paratek Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors Table Paratek Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications Table Paratek Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Cempra, Inc. Basic Information, Manufacturing Base and Competitors Table Cempra, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications Table Cempra, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Debiopharm International S.A. Basic Information, Manufacturing Base and Competitors Table Debiopharm International S.A. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications Table Debiopharm International S.A. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018) Table GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors Table GlaxoSmithKline plc Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications Table GlaxoSmithKline plc Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Furiex Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors Table Furiex Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications Table Furiex Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Melinta Therapeutics, Inc. Basic Information, Manufacturing Base and Competitors Table Melinta Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications Table Melinta Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Actelion Pharmaceuticals Ltd. Basic Information, Manufacturing Base and Competitors Table Actelion Pharmaceuticals Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications Table Actelion Pharmaceuticals Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Durata Therapeutics, Inc. Basic Information, Manufacturing Base and Competitors Table Durata Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications Table Durata Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018) Table MerLion Pharmaceuticals Pte Ltd. Basic Information, Manufacturing Base and Competitors Table MerLion Pharmaceuticals Pte Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications Table MerLion Pharmaceuticals Pte Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Abbott Laboratories, Inc. Basic Information, Manufacturing Base and Competitors Table Abbott Laboratories, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications Table Abbott Laboratories, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Macrolide Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors Table Macrolide Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications Table Macrolide Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Sanofi Basic Information, Manufacturing Base and Competitors Table Sanofi Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications Table Sanofi Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Albany Molecular Research, Inc. Basic Information, Manufacturing Base and Competitors Table Albany Molecular Research, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications Table Albany Molecular Research, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Zavante Therapeutics, Inc. Basic Information, Manufacturing Base and Competitors Table Zavante Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications Table Zavante Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Merck & Co, Inc. Basic Information, Manufacturing Base and Competitors Table Merck & Co, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications Table Merck & Co, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Bayer AG Basic Information, Manufacturing Base and Competitors Table Bayer AG Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications Table Bayer AG Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Allergan plc. Basic Information, Manufacturing Base and Competitors Table Allergan plc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications Table Allergan plc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Teva Pharmaceuticals Industries Ltd. Basic Information, Manufacturing Base and Competitors Table Teva Pharmaceuticals Industries Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications Table Teva Pharmaceuticals Industries Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Pfizer, Inc. Basic Information, Manufacturing Base and Competitors Table Pfizer, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications Table Pfizer, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018) Table AstraZeneca Basic Information, Manufacturing Base and Competitors Table AstraZeneca Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Type and Applications Table AstraZeneca Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue (Million USD) by Players (2014-2019) Table Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Share by Players (2014-2019) Figure Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Share by Players in 2017 Figure Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Share by Players in 2018 Figure Global Top 5 Players Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Share in 2018 Figure Global Top 10 Players Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Share in 2018 Figure Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue (Million USD) and Growth Rate (%) (2014-2019) Table Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue (Million USD) by Regions (2014-2019) Table Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Share by Regions (2014-2019) Figure Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Share by Regions (2014-2019) Figure Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Share by Regions in 2018 Figure North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019) Figure Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019) Figure Asia-Pacific Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019) Figure South America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019) Figure Middle East and Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019) Table North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue by Countries (2014-2019) Table North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Share by Countries (2014-2019) Figure North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Share by Countries (2014-2019) Figure North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Share by Countries in 2018 Figure USA Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019) Figure Canada Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019) Figure Mexico Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019) Table Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue (Million USD) by Countries (2014-2019) Figure Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Share by Countries (2014-2019) Figure Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Share by Countries in 2018 Figure Germany Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019) Figure UK Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019) Figure France Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019) Figure Russia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019) Figure Italy Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019) Table Asia-Pacific Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue (Million USD) by Countries (2014-2019) Figure Asia-Pacific Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Share by Countries (2014-2019) Figure Asia-Pacific Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Share by Countries in 2018 Figure China Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019) Figure Japan Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019) Figure Korea Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019) Figure India Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019) Figure Southeast Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019) Table South America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue by Countries (2014-2019) Table South America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Share by Countries (2014-2019) Figure South America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Share by Countries (2014-2019) Figure South America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Share by Countries in 2018 Figure Brazil Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019) Figure Argentina Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019) Figure Colombia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019) Table Middle East and Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue (Million USD) by Countries (2014-2019) Table Middle East and Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Share by Countries (2014-2019) Figure Middle East and Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Share by Countries (2014-2019) Figure Middle East and Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Share by Countries in 2018 Figure Saudi Arabia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019) Figure UAE Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019) Figure Egypt Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019) Figure Nigeria Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019) Figure South Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue and Growth Rate (2014-2019) Table Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue (Million USD) by Type (2014-2019) Table Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Share by Type (2014-2019) Figure Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Share by Type (2014-2019) Figure Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Share by Type in 2018 Table Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Forecast by Type (2019-2024) Figure Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share Forecast by Type (2019-2024) Figure Global Delafloxacin Revenue Growth Rate (2014-2019) Figure Global Vancomycin Revenue Growth Rate (2014-2019) Figure Global Ceftaroline Fosamil Revenue Growth Rate (2014-2019) Figure Global Others Revenue Growth Rate (2014-2019) Table Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue by Application (2014-2019) Table Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Share by Application (2014-2019) Figure Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Share by Application (2014-2019) Figure Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Share by Application in 2018 Table Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Forecast by Application (2019-2024) Figure Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share Forecast by Application (2019-2024) Figure Global Cellulitis Revenue Growth Rate (2014-2019) Figure Global Abscess Revenue Growth Rate (2014-2019) Figure Global Surgical Wounds Revenue Growth Rate (2014-2019) Figure Global Traumatic Wound Revenue Growth Rate (2014-2019) Figure Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2024) Table Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue (Million USD) Forecast by Regions (2019-2024) Figure Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Share Forecast by Regions (2019-2024) Figure North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Forecast (2019-2024) Figure Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Forecast (2019-2024) Figure Asia-Pacific Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Forecast (2019-2024) Figure South America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Forecast (2019-2024) Figure Middle East and Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Forecast (2019-2024)

Paratek Pharmaceuticals, Inc. Cempra, Inc. Debiopharm International S.A. GlaxoSmithKline plc Furiex Pharmaceuticals, Inc. Melinta Therapeutics, Inc. Actelion Pharmaceuticals Ltd. Durata Therapeutics, Inc. MerLion Pharmaceuticals Pte Ltd. Abbott Laboratories, Inc. Macrolide Pharmaceuticals, Inc. Sanofi Albany Molecular Research, Inc. Zavante Therapeutics, Inc. Merck & Co, Inc. Bayer AG Allergan plc. Teva Pharmaceuticals Industries Ltd. Pfizer, Inc. AstraZeneca